Celldex Therapeutics
Stock Forecast, Prediction & Price Target
Celldex Therapeutics Financial Estimates
Celldex Therapeutics Revenue Estimates
Celldex Therapeutics EBITDA Estimates
Celldex Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $4.65M N/A | $2.35M -49.32% | $6.88M 192.02% | Avg: $3.82M Low: $1.78M High: $6.68M avg. -44.42% | Avg: $2.04M Low: $706.31K High: $3.57M avg. -46.66% | Avg: $89.56M Low: $31.01M High: $156.87M avg. 4290.52% | Avg: $466.82M Low: $161.62M High: $817.65M avg. 421.20% |
Net Income
% change YoY
| $-70.51M N/A | $-122.78M -74.13% | $-141.42M -15.18% | Avg: $-198.25M Low: $-166.18M High: $-118.21M avg. -40.18% | Avg: $-229.8M Low: $-221.41M High: $-110.94M avg. -15.91% | Avg: $-168.36M Low: $-332.84M High: $-25.27M avg. 26.73% | Avg: $31.37M Low: $4.70M High: $62.01M avg. 118.63% |
EBITDA
% change YoY
| $-67.55M N/A | $-101.86M -50.78% | $-139.03M -36.48% | Avg: $-3.82M Low: $-6.68M High: $-1.78M avg. 97.24% | Avg: $-2.04M Low: $-3.57M High: $-706.31K avg. 46.66% | Avg: $-89.56M Low: $-156.87M High: $-31.01M avg. -4290.52% | Avg: $-466.82M Low: $-817.65M High: $-161.62M avg. -421.20% |
EPS
% change YoY
| -$1.64 N/A | -$2.62 -59.75% | -$2.92 -11.45% | Avg: -$2.86 Low: -$3.43 High: -$2.44 avg. 2.01% | Avg: -$3.22 Low: -$4.57 High: -$2.29 avg. -12.46% | Avg: -$3.48 Low: -$6.87 High: -$0.52 avg. -7.98% | Avg: $0.65 Low: $0.1 High: $1.28 avg. 118.63% |
Operating Expenses
% change YoY
| $73.79M N/A | $109.45M 48.31% | $161.42M 47.48% | Avg: $20.42M Low: $9.51M High: $35.67M avg. -87.34% | Avg: $10.89M Low: $3.77M High: $19.08M avg. -46.66% | Avg: $478.29M Low: $165.60M High: $837.74M avg. 4290.52% | Avg: $2.49B Low: $863.12M High: $4.36B avg. 421.20% |
FAQ
What is Celldex Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 22.31% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -166.18M, average is -198.25M and high is -118.21M.
What is Celldex Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 1155.15% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $1.78M, average is $3.82M and high is $6.68M.
What is Celldex Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 25.04% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$3.43, average is -$2.86 and high is $-2.44.
What is the best performing analyst?
In the last twelve months analysts have been covering Celldex Therapeutics stock. The most successful analyst is Joseph Pantginis.